Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Small Molecule CDMO Market Size, Trends, Analysis, and Outlook By Product (Active Pharmaceutical Ingredients (API), Finished Drug Products), By Drug (Innovators, Generics), By Application (Oncology, Cardiovascular Disease, Central Nervous System (CNS) Conditions, Autoimmune/Inflammation, Others), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Small Molecule CDMO market size is poised to register 6.17% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Pharmaceutical Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By ... Read More
-
Stem Cell Therapy Market Size, Trends, Analysis, and Outlook By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source, Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord, Others), By Therapeutic Application, Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular, Others), by Region, Country, Segment, and Companies, 2024-2030
... Inflammatory, Autoimmune, Cardiovascular, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Stem Cell Therapy market size is poised to register 16.8% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Primary Care POC Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Glucose Testing, Hb1Ac Testing, Autoimmune Disease, Coagulation, Fertility, Infectious Diseases, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Urinalysis), By End-user (Pharmacy & Retail Clinics, Physician Office, Urgent Care Clinics, Non-practice Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Urinalysis), By End-user (Pharmacy & Retail Clinics, Physician Office, Urgent Care Clinics, Non-practice Clinics), by Region, Country, Segment, and Companies, 2024-2030 The global Primary ... Read More
-
Point of Care Diagnostics Market Size, Trends, Analysis, and Outlook By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030
... Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030 The global Point ... Read More
-
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Lupus Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency Diseases
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Subcutaneous Immunoglobulins
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Guillain-Barre Syndrome Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Systemic Lupus Erythematosus (SLE) Drugs
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Systematic Lupus Erythematosus Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Autoimmune Disorder Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Immunoglobulins
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Anti-Inflammatory Lupus Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Autoimmune Disease Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Systemic Lupus Erythematosus
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Autoimmune Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Autoimmune Disease Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulins
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency Disease Tests
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
Research Assistance
